Next‑Generation Sequencing Panel for Bethlem Myopathy, Myofibrillar Myopathy, and Ullrich Muscular Dystrophy in UAE | 2600 AED | 2026 DHA Guidelines

تحليل لوحة الجيل التالي للاعتلال العضلي الخلقي (بيتليم، الليفي العضلي، وأولريش) في الإمارات | 2600 درهم | معتمد من هيئة الصحة بدبي

الفحص الجيني المتقدم يُجرى وفق أعلى معايير دقة التشخيص (حساسية 99.9%) مع خدمات سحب منزلي فاخرة وإرشاد طبي هاتفي بعد النتيجة من أطباء معتمدين من هيئة الصحة بدبي.

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Overview

This advanced NGS panel analyzes genes associated with Bethlem myopathy, myofibrillar myopathy, and Ullrich congenital muscular dystrophy to provide a definitive molecular diagnosis. يُعد هذا الفحص الجيني الشامل الأداة التشخيصية القياسية الذهبية للاعتلالات العضلية الوراثية في الإمارات.

Parameter	Our NGS Panel	Traditional Single‑Gene Sequencing
Precision	>99.9% analytical sensitivity & specificity	Lower sensitivity; limited to one gene
Methodology	Next‑Generation Sequencing + Sanger confirmation	Sanger sequencing only
Turnaround Time	40 working days (comprehensive report)	8–12 weeks for multiple genes
Coverage	All coding exons ±20 bp, deep intronic regions	Single gene, partial coverage
Cost‑effectiveness	2600 AED – full panel	Higher cumulative cost for multiple genes

Physician Insight & Safety Protocol

“A genetic diagnosis is not just a result; it is a roadmap for personalized management, family planning, and targeted therapies. I urge patients to review findings with their neurologist before making any medical decisions. Clinical correlation with physical examination and family history is essential.”

— Dr. PRABHAKAR REDDY, DHA License: 61713011

⚠ Medication Warning

Do not discontinue prescribed medication without consulting your doctor.

Exclusion Criteria & ER Red Flags

This test is not intended for acute emergency diagnosis.
If you experience sudden respiratory distress, severe muscle weakness leading to inability to swallow or breathe, or cardiac arrhythmia, seek immediate emergency care.
Patients with known bleeding disorders or severe anemia must discuss with a clinician before blood draw.

Patient FAQ & Clinical Guidance

1. What is the purpose of this test?

This test identifies pathogenic variants in genes causing inherited myopathies, enabling precise diagnosis and tailored management.

يهدف هذا الفحص إلى تحديد الطفرات الجينية المسببة للاعتلالات العضلية الوراثية مما يتيح تشخيصاً دقيقاً وعلاجاً موجهاً.

2. How long does it take to receive results?

Samples are accepted daily by 9 AM; the report is delivered within 40 working days after sample receipt.

تُستلم العينات يومياً حتى الساعة 9 صباحاً وتصدر النتائج خلال 40 يوم عمل من تاريخ الاستلام.

3. Is my genetic data protected and covered by insurance?

All data is handled under UAE PDPL; insurance direct billing is verified via WhatsApp at +971 54 548 8731.

تُعالج جميع البيانات وفقاً لقانون حماية البيانات الشخصية في الإمارات، ويتم التحقق من تغطية التأمين عبر واتساب على الرقم +971 54 548 8731.

Pre‑ Information

Submit 10 mL (5 mL min.) whole blood from 2 Lavender Top (EDTA) tubes. Ship refrigerated. DO NOT FREEZE.
Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.

دعم ثنائي اللغة متاح